Xeris Pharmaceuticals | XERS - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
Celltrion KRW 434.82B 1.14B 2026-03
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Deva Holding AS TRY 5.79B 604.07M 2023-09
Dianthus Therapeutics USD 1.2B 707.91M 2026-03
Divis Laboratories Ltd INR 167.61B 13.48B 2026-03
Eli Lilly USD 31.2B 4.66B 2026-03
Kangmei Pharma CNY 7.31B 84.82M 2026-03
Knight Therapeutics CAD 767.27M 480K 2025-12
Laboratorios Farma EUR 539.39M 22.74M 2023-12
Malin Corporation EUR 193.2M 75M 2024-12
Medical Developments International AUD 54.77M 335K 2025-12
Nektar Therapeutics USD 89.83M 4.75M 2025-12
Neuren Pharmaceuticals AUD 338.45M 15.18M 2025-12
Organigram Holdings CAD 371.81M 2.36M 2026-03
Ovoca Bio EUR 1.26M 7.41M 2025-06
Pacira USD 653.89M 39.22M 2026-03
Perrigo USD 2.5B 436.7M 2026-03
Pharma Mar EUR 249.67M 2.16M 2026-03
Qiagen NV USD 3.33B 446.45M 2026-03
Sartorius EUR 2.82B 96.3M 2026-06
Sino Biopharmaceutical CNY 34B 1.48B 2025-06
Supernus Pharmaceuticals USD 1.08B 15.09M 2026-03
Tilray USD 1.58B 39.08M 2025-09
Zealand Pharma A/S 14.83B 331.99M 2025-12
Zz Pientze Pharmaceu CNY 15.21B 740.32M 2026-03